Related Experiment Video
Updated: Aug 21, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain
Adela G de la Campa1, Luz Balsalobre, Carmen Ardanuy
1Unidad de Genética Bacteriana, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain. agcampa@isciii.es
Abstract:
Among 2,882 Streptococcus pneumoniae sent to the Spanish Reference Laboratory during 2002, 75 (2.6%) were ciprofloxacin-resistant. Resistance was associated with older patients (3.9% in adults and 7.2% in patients > or =65 years of age), with isolation from noninvasive sites (4.3% vs. 1.0%), and with penicillin and macrolide resistance. Among 14 low-level resistant (MIC 4-8 microg/mL) strains, 1 had a fluoroquinolone efflux phenotype, and 13 showed single ParC changes. The 61 high-level ciprofloxacin-resistant (MIC > or =16 microg/mL) strains showed either two or three changes at ParC, ParE, and GyrA. Resistance was acquired either by point mutation (70 strains) or by recombination with viridans streptococci (4 strains) at the topoisomerase II genes. Although 36 pulsed-field gel electrophoresis patterns were observed, 5 international multiresistant clones (Spain23F-1, Spain6B-2, Spain9V-3, Spain14-5 and Sweden15A-25) accounted for 35 (46.7%) of the ciprofloxacin-resistant strains. Continuous surveillance is needed to prevent the dissemination of these clones.
Insights
Ciprofloxacin resistance in Streptococcus pneumoniae is a growing concern, particularly in older adults and with co-resistance to other antibiotics. Surveillance is crucial to monitor and prevent the spread of resistant bacterial clones.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Streptococcus pneumoniae is a significant human pathogen.
- Antibiotic resistance, including to fluoroquinolones like ciprofloxacin, is an increasing global health threat.
- Understanding the mechanisms and epidemiology of resistance is vital for effective treatment strategies.
Purpose of the Study:
- To investigate the prevalence and characteristics of ciprofloxacin-resistant Streptococcus pneumoniae strains in Spain.
- To identify genetic mechanisms and epidemiological factors associated with ciprofloxacin resistance.
- To assess the role of specific bacterial clones in the dissemination of resistance.
Main Methods:
- Analysis of 2,882 Streptococcus pneumoniae isolates collected in 2002.
- Determination of ciprofloxacin minimum inhibitory concentrations (MICs).
- Molecular characterization including gyrA, parC, and parE gene sequencing, pulsed-field gel electrophoresis (PFGE), and assessment of efflux phenotypes.
- Correlation of resistance with patient demographics and isolation site.
Main Results:
- 75 (2.6%) of isolates were ciprofloxacin-resistant.
- Resistance was more common in older patients (> or =65 years) and isolates from noninvasive sites.
- Low-level resistance was associated with single ParC mutations, while high-level resistance involved multiple mutations in gyrA, parC, and parE.
- Resistance mechanisms included point mutations and recombination with viridans streptococci.
- Five international multiresistant clones accounted for 46.7% of resistant strains.
Conclusions:
- Ciprofloxacin resistance in Streptococcus pneumoniae is present in Spain, associated with specific patient groups and genetic alterations.
- Multidrug-resistant clones play a significant role in the epidemiology of resistance.
- Continuous surveillance is essential to control the spread of resistant strains and guide antimicrobial therapy.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial DNA Synthesis
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
